Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2024

Open Access 01-12-2024 | Respiratory Microbiota | Correspondence

Changes in the composition of the fecal metabolome and gut microbiota contribute to intervertebral disk degeneration in a rabbit model

Authors: Shuai Cheng, Jian Yu, Meiling Cui, Hongmin Su, Yang Cao

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2024

Login to get access

Abstract

Purpose

Lower back pain (LBP), mainly caused by intervertebral disk (IVD) degeneration (IDD), is widely prevalent worldwide and is a serious socioeconomic burden. Numerous factors may trigger this degenerative process, and microbial dysbiosis has recently been implicated as one of the likely causes. However, the exact relationship between IDD and the microbiome remains obscure. In this study, we investigated the gut microbiota composition and fecal metabolic phenotype and discussed the possible influences of microbiome dysbiosis on IDD.

Methods

Fecal DNA was extracted from 16 fecal samples (eight rabbit models with IDD and eight sex- and age-matched healthy controls) and analyzed by high-throughput 16S rDNA sequencing. The fecal samples were also analyzed by liquid chromatography–mass spectrometry-based metabolomics. Multivariate analyses were conducted for the relationship between the omics data and IDD, linear discriminant analysis effect size was employed for biomarker discovery. Moreover, the Kyoto Encyclopedia of Genes and Genomes (KEGG) database was used to annotate the differential metabolites. The potential correlation between differential gut microbiota and metabolites was then assessed.

Results

The 16S rDNA sequencing results showed that the β-diversity of the gut microbiota was significantly different between the IDD and control groups, with distinct abundance levels of dominant genera. Moreover, 59 metabolites were significantly upregulated and 91 were downregulated in IDD rabbits versus the controls. The KEGG enrichment analysis revealed that the top pathways remarkably impacted by IDD were tyrosine metabolism, amino sugar and nucleotide sugar metabolism, benzoate degradation, ABC transporters, ascorbate and aldarate metabolism, pantothenate and CoA biosynthesis, and pyrimidine metabolism. The correlation analysis revealed that DL-tyrosine and N-acetylmuramic acid were associated with multiple differential bacterial genera, including Helicobacter and Vibrio, which may play important roles in the process of IVD degeneration.

Conclusion

Our findings revealed that IDD altered gut microbiota and fecal metabolites in a rabbit model. The correlation analysis of microbiota and metabolome provides a deeper understanding of IDD and its possible etiopathogenesis. These results also provide a direction and theoretical basis for the clinical application of fecal transplantation, probiotics, and other methods to regulate gut microbiota in the treatment of LBP caused by IDD.
Literature
1.
go back to reference Hoy D, et al. The global burden of low back pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.PubMedCrossRef Hoy D, et al. The global burden of low back pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74.PubMedCrossRef
3.
go back to reference Fakhoury J, Dowling TJ. Cervical degenerative disc disease. Treasure Island, FL: StatPearls Publishing; 2022. Fakhoury J, Dowling TJ. Cervical degenerative disc disease. Treasure Island, FL: StatPearls Publishing; 2022.
5.
go back to reference Biver E, et al. Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev. 2019;55:100946.PubMedCrossRef Biver E, et al. Gut microbiota and osteoarthritis management: an expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Res Rev. 2019;55:100946.PubMedCrossRef
6.
go back to reference De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85.PubMedCrossRef De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85.PubMedCrossRef
7.
go back to reference Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.PubMedCrossRef Zhang X, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21(8):895–905.PubMedCrossRef
8.
go back to reference Asquith M, et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 2019;71(10):1642–50.PubMedCrossRef Asquith M, et al. HLA alleles associated with risk of ankylosing spondylitis and rheumatoid arthritis influence the gut microbiome. Arthritis Rheumatol. 2019;71(10):1642–50.PubMedCrossRef
10.
go back to reference Coscia MF, Denys GA, Wack MF. Propionibacterium acnes, coagulase-negative Staphylococcus, and the “biofilm-like” intervertebral disc. Spine. 2016;41(24):1860–5.PubMedPubMedCentralCrossRef Coscia MF, Denys GA, Wack MF. Propionibacterium acnes, coagulase-negative Staphylococcus, and the “biofilm-like” intervertebral disc. Spine. 2016;41(24):1860–5.PubMedPubMedCentralCrossRef
11.
go back to reference Capoor MN, et al. A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. Eur Spine J. 2019;28(12):2951–71.PubMedCrossRef Capoor MN, et al. A review of microscopy-based evidence for the association of Propionibacterium acnes biofilms in degenerative disc disease and other diseased human tissue. Eur Spine J. 2019;28(12):2951–71.PubMedCrossRef
13.
go back to reference Steves CJ, et al. The microbiome and musculoskeletal conditions of aging: A review of evidence for impact and potential therapeutics. J Bone Miner Res. 2016;31(2):261–9.PubMedCrossRef Steves CJ, et al. The microbiome and musculoskeletal conditions of aging: A review of evidence for impact and potential therapeutics. J Bone Miner Res. 2016;31(2):261–9.PubMedCrossRef
14.
go back to reference Li W, et al. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Eur Spine J. 2022;31(4):917–25.PubMedCrossRef Li W, et al. Gut-disc axis: A cause of intervertebral disc degeneration and low back pain? Eur Spine J. 2022;31(4):917–25.PubMedCrossRef
15.
go back to reference Tang G, et al. Latent infection of low-virulence anaerobic bacteria in degenerated lumbar intervertebral discs. BMC Musculoskelet Disord. 2018;19(1):445.PubMedPubMedCentralCrossRef Tang G, et al. Latent infection of low-virulence anaerobic bacteria in degenerated lumbar intervertebral discs. BMC Musculoskelet Disord. 2018;19(1):445.PubMedPubMedCentralCrossRef
17.
go back to reference Holmes A, et al. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions. Transl Res. 2020;226:39–56.PubMedPubMedCentralCrossRef Holmes A, et al. Gut dysbiosis and age-related neurological diseases; an innovative approach for therapeutic interventions. Transl Res. 2020;226:39–56.PubMedPubMedCentralCrossRef
18.
19.
go back to reference Li J, et al. Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics. J Clin Investig. 2016;126(6):2049–63.PubMedPubMedCentralCrossRef Li J, et al. Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probiotics. J Clin Investig. 2016;126(6):2049–63.PubMedPubMedCentralCrossRef
20.
go back to reference Li L, et al. Microbial osteoporosis: the interplay between the gut microbiota and bones via host metabolism and immunity. MicrobiologyOpen. 2019;8(8):e00810.PubMedPubMedCentralCrossRef Li L, et al. Microbial osteoporosis: the interplay between the gut microbiota and bones via host metabolism and immunity. MicrobiologyOpen. 2019;8(8):e00810.PubMedPubMedCentralCrossRef
21.
go back to reference Rajasekaran S, et al. Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease. Eur Spine J. 2020;29(7):1621–40.PubMedCrossRef Rajasekaran S, et al. Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease. Eur Spine J. 2020;29(7):1621–40.PubMedCrossRef
23.
go back to reference Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. 2014;26(1):101–7.PubMedPubMedCentralCrossRef Brusca SB, Abramson SB, Scher JU. Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity. Curr Opin Rheumatol. 2014;26(1):101–7.PubMedPubMedCentralCrossRef
24.
go back to reference Jackson MA, et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat Commun. 2018;9(1):2655–2655.PubMedPubMedCentralCrossRef Jackson MA, et al. Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat Commun. 2018;9(1):2655–2655.PubMedPubMedCentralCrossRef
25.
go back to reference Doelman A, et al. Characterization of the gut microbiome in a porcine model of thoracic spinal cord injury. BMC Genom. 2021;22(1):775–775.CrossRef Doelman A, et al. Characterization of the gut microbiome in a porcine model of thoracic spinal cord injury. BMC Genom. 2021;22(1):775–775.CrossRef
27.
go back to reference Rinninella E, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.PubMedPubMedCentralCrossRef Rinninella E, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14.PubMedPubMedCentralCrossRef
28.
go back to reference Sun L, et al. Activation of tyrosine metabolism in CD13+ cancer stem cells drives relapse in hepatocellular carcinoma. Cancer Res Treat. 2020;52(2):604–21.PubMedCrossRef Sun L, et al. Activation of tyrosine metabolism in CD13+ cancer stem cells drives relapse in hepatocellular carcinoma. Cancer Res Treat. 2020;52(2):604–21.PubMedCrossRef
29.
go back to reference Nguyen TN, Nguyen HQ, Le DH. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. PLoS ONE. 2020;15(6):e0229276.PubMedPubMedCentralCrossRef Nguyen TN, Nguyen HQ, Le DH. Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. PLoS ONE. 2020;15(6):e0229276.PubMedPubMedCentralCrossRef
30.
go back to reference Grazzi L, et al. A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache. Cephalalgia. 2019;39(5):655–64.PubMedCrossRef Grazzi L, et al. A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache. Cephalalgia. 2019;39(5):655–64.PubMedCrossRef
31.
go back to reference Xie Y, et al. HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage. Nat Commun. 2019;10(1):4266.PubMedPubMedCentralCrossRef Xie Y, et al. HPD degradation regulated by the TTC36-STK33-PELI1 signaling axis induces tyrosinemia and neurological damage. Nat Commun. 2019;10(1):4266.PubMedPubMedCentralCrossRef
32.
go back to reference Roth L, et al. Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo. Sci Signal. 2019;12(563):eaau0240.PubMedCrossRef Roth L, et al. Phosphorylation of the phosphatase PTPROt at Tyr399 is a molecular switch that controls osteoclast activity and bone mass in vivo. Sci Signal. 2019;12(563):eaau0240.PubMedCrossRef
34.
go back to reference Demirbas D, Brucker WJ, Berry GT. Inborn errors of metabolism with hepatopathy. Pediatr Clin North Am. 2018;65(2):337–52.PubMedCrossRef Demirbas D, Brucker WJ, Berry GT. Inborn errors of metabolism with hepatopathy. Pediatr Clin North Am. 2018;65(2):337–52.PubMedCrossRef
35.
go back to reference Li Y, et al. Comparative transcriptomic analysis reveals that multiple hormone signal transduction and carbohydrate metabolic pathways are affected by Bacillus cereus in Nicotiana tabacum. Genomics. 2020;112(6):4254–67.PubMedCrossRef Li Y, et al. Comparative transcriptomic analysis reveals that multiple hormone signal transduction and carbohydrate metabolic pathways are affected by Bacillus cereus in Nicotiana tabacum. Genomics. 2020;112(6):4254–67.PubMedCrossRef
36.
go back to reference Perri F, et al. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31(4):290–4.PubMed Perri F, et al. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31(4):290–4.PubMed
37.
39.
go back to reference Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503.PubMedCrossRef Shin N-R, Whon TW, Bae J-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496–503.PubMedCrossRef
40.
41.
go back to reference Thevaranjan N, et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe. 2017;21(4):455-466.e4.PubMedPubMedCentralCrossRef Thevaranjan N, et al. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe. 2017;21(4):455-466.e4.PubMedPubMedCentralCrossRef
Metadata
Title
Changes in the composition of the fecal metabolome and gut microbiota contribute to intervertebral disk degeneration in a rabbit model
Authors
Shuai Cheng
Jian Yu
Meiling Cui
Hongmin Su
Yang Cao
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2024
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-023-04486-x

Other articles of this Issue 1/2024

Journal of Orthopaedic Surgery and Research 1/2024 Go to the issue